The Evolving Role of BRCA Testing in Ovarian Cancer

Webinar presenters Dana Chase, MD, FACOG,Assistant Professor, Division of Gynecologic Oncology University of Arizona College of Medicine, Phoenix, AZ, Creighton University School of Medicine at St. Joseph’s Hospital, Phoenix, AZ, Gynecologic Oncologist, Arizona Oncology, and John Longshore, PhD, FACMG, Director, Molecular Pathology, Carolinas Pathology Group, Carolinas HealthCare System, Charlotte, North Carolina, discuss the link between molecular profiles and disease pathogenesis in ovarian cancer, the clinical significance of PARP inhibition in BRCA1 and/or 2–mutated ovarian cancer, the testing process for BRCA mutations, and the evolving paradigms in tumor and germline BRCA testing in ovarian cancer.
Watch Now

Spotlight

OTHER ON-DEMAND WEBINARS

Pharmaron’s cell and gene therapy webinar series

Pharmaron has taken their platform beyond small molecules and are pleased to now offer a full array of services for biologics and cell and gene therapies (CGTs). Our new CGT webinar series focusses on identifying key cell and gene therapy questions that arise during drug discovery and development.
Watch Now

Bioanalytical Methods Validation

Complianceonline

This webinar will review target areas addressed by FDA and EMA current guidance documents and ICH requirements. Current interpretation of guidance documents including failed runs, single stocks for standards and controls. Will address requirements for LC-MS, ligand binding and suggest requirements for cell based assays.
Watch Now

Single-Cell Analysis for Understanding Identity and Diversity

cell.com

The study of single cells has revolutionized our understanding of cell identity, diversity, development, and function, bridging basic science and precision medicine and ushering in technological advances that will revolutionize both. In this Cell Press Webinar,Smita Krishnaswamy (Yale University), John Marioni (EMBL-European Bioinformatics Institute), and Peter Kharchenko (Harvard University) will discuss new methods and tools for analyzing data in the rapidly expanding field of single-cell biology.
Watch Now

Breaking Down Barriers in Healthcare: Urgency for the Clinical Laboratory to Migrate from the Background to the Forefront of Patient Care

Abbott Diagnostics

The movement towards value-based healthcare has provided a platform for a better future for all involved in the health ecosystem. However, amongst the multitude of value initiatives, the clinical laboratory has largely been left to play a secondary role. Despite its core value principles of data, timely and efficient diagnosis, and patient centricity, the lab has been relegated to near-commodity status. This is also indicative of a broader problem: a fragmented value chain that underexploits sources in decision-making, at a time when the health world’s stated focus is on outcomes.
Watch Now

Spotlight

resources